Thyroxine Replacement in Organ Donors
NCT00238030
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Brain Death
Interventions
DRUG:
L-thryoxine
DRUG:
iv thryoxine
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's